Clinical Trials Directory

Trials / Completed

CompletedNCT04841083

Narrow Band Green Light and Migraine

A Real World Evaluation of the Allay Lamp in Reducing Headache Symptoms and Frequency

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
182 (actual)
Sponsor
Vedanta Research · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study volunteers are asked to use the Allay Lamp routinely during the 6-week study period. A web based survey is provided when the Lamp is purchased for study volunteers to complete. A daily usage paper diary is sent with the lamp so that volunteers can keep track of the frequency and duration of lamp usage and any noticeable benefits. At the end of six weeks a second survey is sent to study volunteers to capture their perceptions of potential lamp benefits with respect to headache frequency and their experience of migraine specific symptoms.

Conditions

Interventions

TypeNameDescription
DEVICEAllay LampThe Allay Lamp is a consumer product currently available and widely used in the US. It emits low intensity (1-10 lux) narrow band (20 nm) green light (peak wavelength 520 nm) that is marketed as non-irritating to users. In that context, it is not a medical device and does not require a 510(k).

Timeline

Start date
2020-12-15
Primary completion
2022-06-15
Completion
2022-12-05
First posted
2021-04-12
Last updated
2022-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04841083. Inclusion in this directory is not an endorsement.